Health and Science Technology Commercialization
Speeding Innovation From Lab to Market
Science and technology innovation is helping solve our most challenging health problems. To rapidly move a solution from idea to impact, we help public and private partners navigate funding hurdles and technical challenges—such as regulatory requirements, market access, and clinical utility—speeding up these processes from years to months. We have nearly three decades of expertise in bringing innovative technology solutions to Americans through funding, training, investments, and network support.
We help innovation happen now.
Our Services and Impact
Impact By the Numbers
- 250+ funded innovators
- 7 billion COVID-19 tests produced
- 5 months from clinical trial start to market for first rapid hepatitis C test
- $124 million in women’s health funding facilitated
We use our expertise in government funding and contract management, as well as our extensive networks, to provide the infrastructure to support new technologies. We provide award management support, negotiating, executing, and managing awards to qualified innovators and entrepreneurs, and help them move closer to commercialization.
Our services include:
- Digital health
- Analytical and bench testing
- Tissue engineering and biomaterials
- Medtech, including wearables and apps
- Diagnostics (IVDs)
- Human subjects research (HSR)
- Pre-clinical models
- Accessibility
- Design thinking
- Broadening perspectives
- Quantitative/data science
- Sustainability in design
- Intellectual property
- Technology transfer / licensing and deal negotiations
- Startup and commercialization acceleration
If you are interested in joining our expert network, explore our information for vendors and consultants.
Our Portfolio
We expand the capacity of government-funded programs in advancing solutions in a broad range of health areas, including cancer, cardiovascular disease, hepatitis B and C viruses, HIV, mpox and other lesion-causing diseases, neurodegenerative diseases, osteoarthritis, respiratory viruses (COVID-19, influenza A/B, RSV), substance use disorder, and women’s health.
RADx® Tech
The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program works to advance diagnostic devices, wearables, and remote sensing technologies. We serve as a critical facilitator within the RADx® Tech initiatives by providing resources, networks, and support that allow medical device companies to move technologies more quickly to consumers. Our network of commercialization experts includes professionals within technical, business, regulatory, and other fields when identified by our participating companies.
We also support NIH RADx® Innovation Funnel programs, programs modeled after the RADx® Tech program, which help accelerate the commercialization of technologies to more accurately diagnose and treat infectious diseases (e.g. mpox, HIV, HBV), to improve maternal health outcomes (e.g., endometriosis), and to screen for cancer.
Blueprint MedTech
The NIH Blueprint MedTech Program aims to speed the development of cutting-edge technologies to diagnose and treat disorders of the central nervous system. On the path from lab to market, this program moves neurotechnologies from early-stage development to human-grade prototypes ready for clinical trials.
We accelerate Blueprint innovator projects by sourcing, managing, and contracting with an experienced network of vendors and consultants to both support product development and de-risk barriers to commercialization.
Investor Catalyst Hub
VentureWell served as the consortium management firm for the Advanced Research Projects Agency for Health (ARPA-H) Investor Catalyst Hub from September 2023 to February 2026. One of three regional hubs in ARPA-H’s health innovation network, we connected researchers, entrepreneurs, and investors to accelerate the development of groundbreaking healthcare solutions. We supported a business model emphasizing rapid and innovative healthcare solutions and making pivotal investments in areas that cannot readily be accomplished through traditional research or commercial activity.
VentureWell managed and grew the Investor Catalyst Hub innovator network to more than 700 organizations worldwide, and supported ARPA-H programs from discovery and concept development through award management. With our expertise in navigating the complexities of the business, transition, and regulatory landscapes, we provided technical and commercialization support, contracting and vendor management, and research and data services to drive successful outcomes for ARPA-H–awarded performers. Learn more about our role.
VentureWell currently supports award management for the ARPA-H Sprint for Women’s Health, providing commercialization support and managing milestone delivery for the 23 performers’ $113 million portfolio over the two-year award period.
Biomedical Engineering
In collaboration with the National Institute of Biomedical Imaging and Bioengineering (NIBIB), we host the annual Design by Biomedical Undergraduate Teams (DEBUT) Challenge. The DEBUT competition awards undergraduate student teams with promising novel technologies. Teams with working prototypes are judged on impact, patentability, market potential, and innovative design.
We also support the biennial Biomedical Engineering Innovation, Design, and Entrepreneurship Alliance (BME-IDEA) Meeting and related BME-IDEA programs. This event fosters collaboration among educators, researchers, and industry leaders. We facilitate keynotes and workshops, grow the global biomedical engineering network, and support educators in integrating entrepreneurship and commercialization into biomedical engineering curricula.